• Pharma
  • June 8, 2024
  • 229 views
CDSCO panel gives nod for continuation of phase-II clinical trial of SII’s dengue vaccine

New Delhi: An expert committee under the Central Drug Regulatory Authority has recommended continuation of phase II clinical trial of the Serum Institute Of India (SII)’s vaccine against dengue after…